Grünenthal Pharma GmbH & Co. KG

The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. We are an entrepreneurial specialist delivering true benefits to patients. This distinguishes us from others. To satisfy this claim, we need a special corporate culture, which is understood and lived by all employees. With “Be!Grünenthal” we offer a tangible guide for action for our daily work in which we have defined the mindsets and behaviors necessary for fulfilling our task of achieving optimum results for patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. The Grünenthal Group is present in 32 countries with affiliates in Europe, Australia, Latin America and the US. Grünenthal products are sold in more than 155 countries and currently approx. 5,300 employees are working for the Grünenthal Group worldwide. In 2015, Grünenthal achieved revenues of € 1.2 bn.